US equities
|
MU
$1,045.06
▼-1.88%
NVDA
$230.47
▲+0.92%
SNDK
$1,738.83
▼-0.06%
TSLA
$356.20
▲+0.39%
INTC
$119.67
▼-0.47%
SPCX
$151.24
▲+0.25%
GOOGL
$339.94
▼-1.20%
AMD
$611.25
▼-0.08%
MU
$1,045.06
▼-1.88%
NVDA
$230.47
▲+0.92%
SNDK
$1,738.83
▼-0.06%
TSLA
$356.20
▲+0.39%
INTC
$119.67
▼-0.47%
SPCX
$151.24
▲+0.25%
GOOGL
$339.94
▼-1.20%
AMD
$611.25
▼-0.08%
FinancialContent
Watchlist
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
My watchlist
My portfolio
Recent quotes
Latest News about Clinical Trial Amendments
Recent news which mentions Clinical Trial Amendments
Annovis Bio Gets FDA Nod For Late-Stage Parkinson Disease Study Amendments
July 07, 2022
Tickers
ANVS
Tags
Movers & Shakers
Market News
Clinical Trial Amendments
From
Benzinga